Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

2.4K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
2.4K
Ion Channels01:19

Ion Channels

90.8K
The movement of ions like sodium, potassium, and calcium into and out of the cell is essential to maintain the electrochemical gradient in living cells. The ion channels—a class of membrane transport proteins—help maintain this ionic gradient for the smooth functioning of physiological activities such as maintaining cell size and volume, conducting nerve impulses, and gas and nutrient exchange.
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
90.8K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

1.7K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.1K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.0K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.0K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

626
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
626

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The International Pediatric Headache Didactic Series: A Novel Curriculum Innovation.

Headache·2026
Same author

Lifestyle Contributors to Frequent Headaches in Youth: Exploring Beyond the Obvious Into the Overlooked.

Neurology·2024
Same author

A retrospective analysis of the use of candesartan for migraine prevention in adolescents.

Headache·2024
Same author

Melatonin for migraine prevention in children and adolescents: A randomized, double-blind, placebo-controlled trial after single-blind placebo lead-in.

Headache·2023
Same author

Headache in Adolescents.

Neurologic clinics·2022
Same author

Managing Headache Disorders Associated with Tuberous Sclerosis and Neurofibromatosis.

Current pain and headache reports·2022

Related Experiment Video

Updated: Dec 25, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.6K

Migraine Pathophysiology.

William Qubty1, Irene Patniyot2

  • 1Pediatric Headache Center, Department of Neurology, Dell Medical School at the University of Texas at Austin, Austin, Texas.

Pediatric Neurology
|March 21, 2020
PubMed
Summary
This summary is machine-generated.

Migraine, a leading cause of disability, involves distinct phases: premonitory, aura, headache, and postdrome. Understanding these neurological stages, including hypothalamic and cortical spreading depolarization, aids migraine management.

Keywords:
AuraCalcitonin gene-related peptide (CGRP)HeadacheMigrainePathophysiologyPituitary adenylate cyclase-activating polypeptide (PACAP)

More Related Videos

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents
08:39

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents

Published on: May 16, 2022

2.8K
Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

9.4K

Related Experiment Videos

Last Updated: Dec 25, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.6K
Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents
08:39

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents

Published on: May 16, 2022

2.8K
Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

9.4K

Area of Science:

  • Neurology
  • Neuroscience

Background:

  • Migraine is a significant cause of disability, particularly in adults aged 15-49.
  • Understanding of this complex neurological disorder has evolved considerably over the past 30 years.

Purpose of the Study:

  • To review the characterized phases of migraine.
  • To explore the neuroanatomical, chemical, and neuroimaging correlates of each migraine phase.

Main Methods:

  • Review of current scientific literature on migraine pathophysiology.
  • Analysis of findings from behavioral changes and functional neuroimaging studies.
  • Examination of implicated neuropeptides and neuronal mechanisms.

Main Results:

  • The premonitory phase suggests hypothalamic involvement.
  • Migraine aura is linked to cortical spreading depolarization.
  • The headache phase involves trigeminocervical complex activation, with calcitonin gene-related peptide as a therapeutic target.
  • The postdrome phase includes various neuropsychiatric and sensory symptoms.

Conclusions:

  • Elucidating migraine phase mechanisms improves comprehension of migraine symptomatology.
  • This understanding can assist in evaluating novel therapeutics for migraine management.